COVID-19 and metabolic diseases: a heightened awareness of health inequities and a renewed focus for research priorities.
Cell Metab
; 33(3): 473-478, 2021 03 02.
Article
in English
| MEDLINE | ID: covidwho-1074686
ABSTRACT
Chronic metabolic disorders such as diabetes and obesity are major public health issues in the United States. However, significant disparities in their prevalence and incidence place a greater burden on US racial and ethnic minority groups, contributing to worse COVID-19 outcomes in many. Improving treatment and prevention of diabetes and obesity is critical to the NIDDK. In this Perspective, we will review the burden of metabolic diseases in the United States, the observed disparities for metabolic diseases in relation to COVID-19, and research opportunities to address underlying causes of metabolic diseases, their associated health disparities, and COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
Healthcare Disparities
/
COVID-19
/
Metabolic Diseases
/
Obesity
Type of study:
Experimental Studies
/
Observational study
/
Randomized controlled trials
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Cell Metab
Journal subject:
Metabolism
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS